Managing the risk of pregnancy for teratogenic drugs used in dermatology. (Symposia Highlights).
Publication: Skin & Allergy News
Publication Date: 01-JAN-02
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
Approximately 50% of all pregnancies in the United States are unintended, the highest rate among all industrialized nations. Unintended pregnancy can be particularly devastating when conception occurs during treatment with a teratogenic drug. This issue is especially pertinent to dermatologists who regularly prescribe numerous drugs that have documented...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
